Sarilumab Beneficial for Polymyalgia Rheumatica Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficaci…
Learn MoreSarilumab Beneficial for Polymyalgia Rheumatica Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficaci…
Learn MoreSevere SARS-CoV-2 Appears to Infect Coronary Vessels
THURSDAY, Oct. 5, 2023 (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seems to infect coronary vessels, inducing plaque inflammation, according to a study published online Sept. 28 in Nature Cardiovascular Research.No…
Learn MoreSevere SARS-CoV-2 Appears to Infect Coronary Vessels
THURSDAY, Oct. 5, 2023 (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seems to infect coronary vessels, inducing plaque inflammation, according to a study published online Sept. 28 in Nature Cardiovascular Research.No…
Learn MoreSimilar Management Seen for Dialysis-Requiring AKI, ESKD Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the potential to recover, according to a…
Learn MoreSimilar Management Seen for Dialysis-Requiring AKI, ESKD Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the potential to recover, according to a…
Learn MoreIVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy
THURSDAY, Oct. 5, 2023 (HealthDay News) — Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA) therapy have infections, and the rate of infections is significantly lower when patients are receiving intravenous immuno…
Learn MoreIVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy
THURSDAY, Oct. 5, 2023 (HealthDay News) — Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA) therapy have infections, and the rate of infections is significantly lower when patients are receiving intravenous immuno…
Learn MoreHigher, Lower HDL Cholesterol Linked to Increased Risk for Dementia
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Higher and lower levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for Alzheimer disease and related dementia (ADRD), according to a study published online Oct. 4 i…
Learn MoreChatbots Generate Mostly Accurate Information to Medical Queries
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Chatbots generate mostly accurate information to physician-developed medical queries, according to a study published online Oct. 2 in JAMA Network Open.Rachel S. Goodman, from the Vanderbilt University Schoo…
Learn More